Fig. 4

ROC curves and calibration curve for the prediction of survival outcome. ROC curves and AUROCs for the prediction of survival outcome within 3 year (a) and 5 years (b) among HCC patients after RT in the training cohort, 3 year (c) and 5 years (d) among HCC patients after RT in the validation cohort. Calibration curve for the prediction of survival outcome within 3 years among uHCC patients after RT in the training cohort (e) and validation cohort (f). Nomogram: post-SII + delta-NLR + BCLC + enlarged spleen; Model1: delta-NLR + BCLC + enlarged spleen; Model2: post-SII + BCLC + enlarged spleen; Model3: BCLC + enlarged spleen. Model4: BCLC